PCM
CLCD

Pentwater Capital Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Pentwater Capital Management’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-26,234
Closed -$220K – 117
2015
Q4 		$220K Sell
26,234
-457,452
-95% -$2.41M ﹤0.01% 103
2015
Q3 		$1.87M Sell
483,686
-76,855
-14% -$568K 0.02% 110
2015
Q2 		$4.99M Buy
+560,541
New +$4.81M 0.03% 118

Other funds holding CLCD

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Pentwater Capital Management's CLCD Position: Q1 2016 in Review

Pentwater Capital Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2016, closing a stake of 26,234 shares — an estimated $220K sold.

Pentwater Capital Management first reported a position in CLCD in Q2 2015 and held it in 3 quarters. The position peaked at $4.99M in Q2 2015. 22 funds tracked by Wall St. Rank hold CLCD as of Q1 2016.

  • Pentwater Capital Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Pentwater Capital Management sold 26,234 CoLucid Pharmaceuticals, Inc. shares in Q1 2016, an estimated $220K.
  • Pentwater Capital Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q2 2015 and held it in 3 quarters.
  • Pentwater Capital Management's CoLucid Pharmaceuticals, Inc. position peaked at $4.99M in Q2 2015.
  • 22 funds tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2016.

Based on Pentwater Capital Management's 13F filing for Q1 2016, filed 16 May 2016.